Jennifer E. Cook sold $2.8M of BridgeBio Pharma (BBIO)

Executed Jun 23, disclosed Jun 24, 1 day later.

Value, as filed

$2.8M

39,363 sh across 2 lots

Executed

Jun 23

the trade date, as filed

Disclosed

Jun 24

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Jennifer E. Cook Director profile →

Jennifer E. Cook (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $13.2M of BBIO (148,589 sh across 2 lots, as filed), executed Jul 9.

The name

BBIO

BridgeBio Pharma, Inc. BBIO · Healthcare · 71 filings in 24 months ticker →

Healthcare · BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jennifer E. Cook in BBIO

BBIOSALE BridgeBio Pharma, Inc. $13.2M
148,589 sh across 2 lots
Exec Jul 9
Filed Jul 13 · 4:40 PM ET BBIOSALE BridgeBio Pharma, Inc. $6.0M
90,240 sh across 2 lots
Exec Jun 15
Filed Jun 17 · 5:30 PM ET